In this current study we show in primary RCC tumours correlation between the increased expression of pERK-1/2 and Cav-1, and that their combined expression serves as a more powerful predictor of disease recurrence than tumour stage or pERK-1/2 or Cav-1 alone. The gene discussed is CAV1; the disease is renal cell carcinoma.